Dr. Ronald B Natale MD Medical Oncologist

Dr. Ronald Natale is a medical oncologist in West Hollywood, California. He is affiliated with multiple hospitals in the area, including Cedars-Sinai Medical Center and Ronald Reagan University of California Los Angeles Medical Center. He received his medical degree from Wayne State University School of Medicine and has been in practice for 40 years. He is one of 28 doctors at Cedars-Sinai Medical Center and one of 35 at Ronald Reagan University of California Los Angeles Medical Center who specialize in Medical Oncology.

Are you Dr. Ronald Natale? Claim your profile to make edits or add details. Claim/Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Medical Oncologist: General Oncology

Hospital Affiliation

Cedars-Sinai Medical Center
Ranked #26 in Cancer

Ronald Reagan University of California Los Angeles Medical Center
Ranked #11 in Cancer

Education & Medical Training

Wayne State University School of Medicine
Residency, Internal Medicine, 1974 - 1976

Memorial Sloan-Kettering Cancer Center
Fellowship, Medical Oncology, 1977 - 1980

Wayne State University School of Medicine
Class of 1974

Certifications & Licensure

American Board of Internal Medicine
Certified in Internal Medicine

American Board of Internal Medicine
Certified in Medical Oncology

CA State Medical License

Publications & Presentations

Phase II study of sunitinib as maintenance therapy in patients with locally advanced or metastatic non-small cell lung cancer.
Gervais, R., Hainsworth, J.D., Blais, N., Besse, B., Laskin, J., Hamm, J.T., Lipton, A., Albain, K.S., Masters, G.A., Natale, R.B., Selaru, P., Kim, S.T., Chao, R.C., Page, R.D.

Phase III trial of vandetanib compared with erlotinib in patients with previously treated advanced non-small-cell lung cancer.
Natale, R.B., Thongprasert, S., Greco, F.A., Thomas, M., Tsai, C., Sunpaweravong, P., Ferry, D., Mulatero, C., Whorf, R., Thompson, J., Barlesi, F., Langmuir, P., Gogov, S., Rowbottom, J.A., Goss, G.D.

Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-Directed Intergroup Study (S8710).

See all 30 publications
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by

Specialty

Location

Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.